Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma
- 1 September 2008
- journal article
- other
- Published by Elsevier BV in Journal of Dermatological Science
- Vol. 51 (3), 210-215
- https://doi.org/10.1016/j.jdermsci.2008.04.008
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Overexpression of phosphorylated ATF2 and STAT3 in eccrine porocarcinoma and eccrine poromaJournal of Dermatological Science, 2008
- Tumor Necrosis Factor Receptor 1/c-Jun-NH2-Kinase Signaling Promotes Human NeoplasiaCancer Research, 2007
- Overexpression of Phosphorylated-STAT3 Correlated with the Invasion and Metastasis of Cutaneous Squamous Cell CarcinomaThe Journal of Dermatology, 2005
- Activation of Cyclin D1 by Estradiol and Spermine in MCF-7 Breast Cancer Cells: A Mechanism Involving the p38 MAP Kinase and Phosphorylation of ATF-2Oncology Research, 2005
- IFNα induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signalingOncogene, 2003
- Death receptors and melanoma resistance to apoptosisOncogene, 2003
- An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasisJCI Insight, 2002
- Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma linesInternational Journal of Cancer, 2002
- Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascadesOncogene, 1997